Brand-name drug
Jornay price, strengths & recalls
Brand of methylphenidate (generic)
Pharmacies pay $462.05 for 30 capsules of Jornay 60 mg extended-release capsule this week, and from $461.38 to $462.18 across its 5 priced strengths and forms. The generic, methylphenidate, costs pharmacies from $3.65. It is in shortage (unavailable). It has 24 recalls on record, none ongoing. Its official label last changed on November 17, 2025.
UnavailableBrand- Fair cash price
- $541.86
- Strengths
- 5
- Makers
- 1
- Updated
- Nov 11
Jornay price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 20 mg extended-release capsule Brand | $15.38 | $461.52 / 30 capsules |
| 40 mg extended-release capsule Brand | $15.41 | $462.18 / 30 capsules |
| 60 mg extended-release capsule Brand | $15.40 | $462.05 / 30 capsules |
| 80 mg extended-release capsule Brand | $15.40 | $461.96 / 30 capsules |
| 100 mg extended-release capsule Brand | $15.38 | $461.38 / 30 capsules |
The lowest cost per capsule is 100 mg extended-release capsule at $15.38. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Jornay vs generic methylphenidate
GenericMethylphenidate pricesSupply status: shortages & recalls
Shortages
- Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)
- Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)Allocation to current contracted customers
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)
- Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)
- Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)Temporary discontinuation of 100ct
- Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)Temporary discontinuation of 100ct
- Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)Allocation to current contracted customers
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)Allocation to current contracted customers
- Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)Allocation to current contracted customers
- Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 24 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Jornay
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use JORNAY PM® safely and effectively. See full prescribing information for JORNAY PM. JORNAY PM (methylphenidate hydrochloride) extended-release capsules, for oral use, CII Initial U.S. Approval: 1955
WARNING: ABUSE, MISUSE, AND ADDICTION
JORNAY PM has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including JORNAY PM, can result in overdose and death
[see Overdosage (10)], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.
Before prescribing JORNAY PM, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout JORNAY PM treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse and addiction
[see Warnings and Precautions (5.1) and Drug Abuse and Dependence (9.2)].
WARNING: ABUSE, MISUSE AND ADDICTION
See full prescribing information for complete boxed warning.
JORNAY PM has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including JORNAY PM, can result in overdose and death (5.1, 9.2, 10):
Before prescribing JORNAY PM, assess each patient's risk for abuse, misuse, and addiction.
Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.
Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
Recent major changes (as listed on the label)
Indications and Usage (1)
| 09/2025
|
Warnings and Precautions (5.7)
| 09/2025
|
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA209311 · Ironshore Pharms
- First approved
- August 8, 2018 (8 years ago)
- Latest approved change
- August 20, 2026
- Approved label
- PDF, Sep 28, 2026
- Generic makers
- 31 approved generic applications on the market
- Last patent listed
- March 23, 2032
Jornay questions
How much does jornay cost without insurance?
Pharmacies pay about $462.05 for 30 capsules of jornay 60 mg extended-release capsule ($15.40 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $541.86. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Jornay?
Yes: methylphenidate. Pharmacies pay from $3.65 for it. Compare methylphenidate prices.
Is jornay in shortage?
Yes. 38 products are listed as in shortage or being discontinued (unavailable). See which ones.
Has jornay been recalled?
24 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the jornay label last change?
The official label was last updated on November 17, 2025 (version 16). See what changed.
Talk about jornay
No comments yet. Questions, tips, what worked for you - start the conversation.